[Skip to Content]
[Skip to Content Landing]
Views 1,214
Citations 0
Clinical Trials Update
November 28, 2017

Continuous Glucose Monitoring in Pregnant Women With Diabetes

JAMA. 2017;318(20):1968. doi:10.1001/jama.2017.17951

Continuous glucose monitoring (CGM) in pregnant women with type 1 diabetes was associated with improved neonatal outcomes, according to a trial published in The Lancet.

The 325 women with type 1 diabetes (215 pregnant, 110 planning pregnancy) were randomly assigned to CGM in addition to capillary glucose monitoring or to standard capillary glucose monitoring alone (control).